Moreover, Navarro et al. reported that the detection of GAL-1 circulating levels shows strong potential for use as a novel biomarker for the diagnosis of pancreatic ductal adenocarcinoma (PDA) patients [53]. The gene discussed is LGALS1; the disease is Patent ductus arteriosus.